The remarkable frequency of human immunodeficiency virus type 1 genetic recombination

Microbiology and Molecular Biology Reviews

Volumn 73, Issue 3, 2009, Pages 451-480

  Onafuwa Nuga, Adewunmi ^a   Telesnitsky, Alice ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DIMER; GENOMIC RNA; MONOMER; RNA DIRECTED DNA POLYMERASE; VIRUS MESSENGER RNA; VIRUS RNA;

DIMERIZATION; DNA PACKAGING; DNA TEMPLATE; GENE DELETION; GENE DUPLICATION; GENE SEQUENCE; GENE SWITCHING; GENETIC REASSORTMENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INDEL MUTATION; INTRACELLULAR SPACE; MIXED INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PERSISTENT VIRUS INFECTION; REGULATORY MECHANISM; RETROVIRUS; REVIEW; VIRAL GENE DELIVERY SYSTEM; VIRION; VIRUS INFECTIVITY; VIRUS NUCLEOCAPSID; VIRUS ONCOGENE; VIRUS RECOMBINATION;

EVOLUTION, MOLECULAR; GENOME, VIRAL; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; RECOMBINATION, GENETIC; RNA, VIRAL;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 70349303282     PISSN: 10922172     EISSN: None     Source Type: Journal    
DOI: 10.1128/MMBR.00012-09     Document Type: Review

References (368)

1. Abbink, T. E., and B. Berkhout. 2003. A novel long distance base-pairing interaction in human immunodeficiency virus type 1 RNA occludes the Gag start codon. J. Biol. Chem. 278:11601-11611.
2. Abbondanzieri, E. A., G. Bokinsky, J. W. Rausch, J. X. Zhang, S. F. Le Grice, and X. Zhuang. 2008. Dynamic binding orientations direct activity of HIV reverse transcriptase. Nature 453:184-189. (Pubitemid 351667984)
3. Abecasis, A. B., P. Lemey, N. Vidal, T. de Oliveira, M. Peeters, R. Camacho, B. Shapiro, A. Rambaut, and A. M. Vandamme. 2007. Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form. J. Virol. 81:8543-8551.
4. Allen, T. M., and M. Altfeld. 2003. HIV-1 superinfection. J. Allergy Clin. Immunol. 112:829-835.
5. + T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J. Virol. 79:13239-13249.
6. Altfeld, M., T. M. Allen, X. G. Yu, M. N. Johnston, D. Agrawal, B. T. Korber, D. C. Montefiori, D. H. O'Connor, B. T. Davis, P. K. Lee, E. L. Maier, J. Harlow, P. J. Goulder, C. Brander, E. S. Rosenberg, and B. D. Walker. 2002. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 420:434-439. (Pubitemid 35415656)
7. Althaus, C. L., and S. Bonhoeffer. 2005. Stochastic interplay between mutation and recombination during the acquisition of drug resistance mutations in human immunodeficiency virus type 1. J. Virol. 79:13572-13578. (Pubitemid 41508169)
8. An, W., and A. Telesnitsky. 2002. Effects of varying sequence similarity on the frequency of repeat deletion during reverse transcription of a human immunodeficiency virus type 1 vector. J. Virol. 76:7897-7902. (Pubitemid 34761014)
9. An, W., and A. Telesnitsky. 2001. Frequency of direct repeat deletion in a human immunodeficiency virus type 1 vector during reverse transcription in human cells. Virology 286:475-482. (Pubitemid 32721823)
10. Reference deleted.
11. An, W., and A. Telesnitsky. 2002. HIV-1 genetic recombination: experimental approaches and observations. AIDS Rev. 4:195-212. (Pubitemid 36104231)
12. An, W., and A. Telesnitsky. 2004. Human immunodeficiency virus type 1 transductive recombination can occur frequently and in proportion to polyadenylation signal readthrough. J. Virol. 78:3419-3428. (Pubitemid 38568283)
13. Andersen, E. S., R. E. Jeeninga, C. K. Damgaard, B. Berkhout, and J. Kjems. 2003. Dimerization and template switching in the 5′ untranslated region between various subtypes of human immunodeficiency virus type 1. J. Virol. 77:3020-3030. (Pubitemid 36228087)
14. Anderson, J. A., E. H. Bowman, and W.-S. Hu. 1998. Retroviral recombination rates do not increase linearly with marker distance and are limited by the size of the recombining subpopulation. J. Virol. 72:1195-1202.
15. Anderson, J. A., R. I. Teufel, P. D. Yin, and W.-S. Hu. 1998. Correlated template-switching events during minus-strand DNA synthesis: a mechanism for high negative interference during retroviral recombination. J. Virol. 72:1186-1194.
16. Anderson, J. P., R. Daifuku, and L. A. Loeb. 2004. Viral error catastrophe by mutagenic nucleosides. Annu. Rev. Microbiol. 58:183-205.
17. Archer, J., J. W. Pinney, J. Fan, E. Simon-Loriere, E. J. Arts, M. Negroni, and D. L. Robertson. 2008. Identifying the important HIV-1 recombination breakpoints. PLoS Comput. Biol. 4:e1000178.
18. Arnaud, F., M. Caporale, M. Varela, R. Biek, B. Chessa, A. Alberti, M. Golder, M. Mura, Y. P. Zhang, L. Yu, F. Pereira, J. C. Demartini, K. Leymaster, T. E. Spencer, and M. Palmarini. 2007. A paradigm for virus-host coevolution: sequential counter-adaptations between endogenous and exogenous retroviruses. PLoS Pathog. 3:e170. (Pubitemid 350291607)
19. Ashe, M. P., P. Griffin, W. James, and N. J. Proudfoot. 1995. Poly(A) site selection in the HIV-1 provirus: inhibition of promoter-proximal polyadenylation by the downstream major splice donor site. Genes Dev. 9:3008-3025.
20. + T cells. J. Virol. 80:6441-6457.
21. Baird, H. A., R. Galetto, Y. Gao, E. Simon-Loriere, M. Abreha, J. Archer, J. Fan, D. L. Robertson, E. J. Arts, and M. Negroni. 2006. Sequence determinants of breakpoint location during HIV-1 intersubtype recombination. Nucleic Acids Res. 34:5203-5216. (Pubitemid 44742485)
22. Baird, H. A., Y. Gao, R. Galetto, M. Lalonde, R. M. Anthony, V. Giacomoni, M. Abreha, J. J. Destefano, M. Negroni, and E. J. Arts. 2006. Influence of sequence identity and unique breakpoints on the frequency of intersubtype HIV-1 recombination. Retrovirology 3:91.
23. Balakrishnan, M., B. P. Roques, P. J. Fay, and R. A. Bambara. 2003. Template dimerization promotes an acceptor invasion-induced transfer mechanism during human immunodeficiency virus type 1 minus-strand synthesis. J. Virol. 77:4710-4721. (Pubitemid 36402821)
24. Balint, A., V. Palfi, S. Belak, and C. Baule. 2005. Viral sequence insertions and a novel cellular insertion in the NS2 gene of cytopathic isolates of bovine viral diarrhea virus as potential cytopathogenicity markers. Virus Genes 30:49-58. (Pubitemid 40365076)
25. Banks, J. D., B. O. Kealoha, and M. L. Linial. 1999. An MY-containing heterologous RNA, but not env mRNA, is efficiently packaged into avian retroviral particles. J. Virol. 73:8926-8933.
26. Basu, V. P., M. Song, L. Gao, S. T. Rigby, M. N. Hanson, and R. A. Bambara. 2008. Strand transfer events during HIV-1 reverse transcription. Virus Res. 134:19-38.
27. Becher, P., M. Orlich, and H. J. Thiel. 1998. Ribosomal S27a coding sequences upstream of ubiquitin coding sequences in the genome of a pestivirus. J. Virol. 72:8697-8704. (Pubitemid 28471810)
28. Berkhout, B., A. Grigoriev, M. Bakker, and V. V. Lukashov. 2002. Codon and amino acid usage in retroviral genomes is consistent with virus-specific nucleotide pressure. AIDS Res. Hum. Retrovir. 18:133-141.
29. Berkowitz, R., J. Fisher, and S. P. Goff. 1996. RNA packaging. Curr. Top. Microbiol. Immunol. 214:177-218.
30. Bircher, L. A., J. C. Rigano, V. G. Ponferrada, and D. P. Wooley. 2002. High fidelity of homologous retroviral recombination in cell culture. Arch. Virol. 147:1665-1683.
31. Bishop, K. N., M. Verma, E. Y. Kim, S. M. Wolinsky, and M. H. Malim. 2008. APOBEC3G inhibits elongation of HIV-1 reverse transcripts. PLoS Pathog. 4:e1000231.
32. Blackard, J. T., D. E. Cohen, and K. H. Mayer. 2002. Human immunode- ficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences. Clin. Infect. Dis. 34:1108-1114.
33. Blankson, J. N., D. Persaud, and R. F. Siliciano. 2002. The challenge of viral reservoirs in HIV-1 infection. Annu. Rev. Med. 53:557-593.
34. Bonhoeffer, S., C. Chappey, N. T. Parkin, J. M. Whitcomb, and C. J. Petropoulos. 2004. Evidence for positive epistasis in HIV-1. Science 306:1547-1550.
35. Bosch, M. L., A. C. Andeweg, R. Schipper, and M. Kenter. 1994. Insertion of N-linked glycosylation sites in the variable regions of the human immunodeficiency virus type 1 surface glycoprotein through AAT triplet reiteration. J. Virol. 68:7566-7569.
36. Bowerman, B., P. O. Brown, J. M. Bishop, and H. E. Varmus. 1989. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev. 3:469-478.
37. Brincat, J. L., J. K. Pfeiffer, and A. Telesnitsky. 2002. RNase H activity is required for high-frequency repeat deletion during Moloney murine leukemia virus replication. J. Virol. 76:88-95.
38. Brown, P. H., L. S. Tiley, and B. R. Cullen. 1991. Efficient polyadenylation within the human immunodeficiency virus type 1 long terminal repeat requires flanking U3-specific sequences. J. Virol. 65:3340-3343.
39. Browning, M. T., R. D. Schmidt, K. A. Lew, and T. A. Rizvi. 2001. Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions. J. Virol. 75:5129-5140.
40. Buiser, R. G., J. J. DeStefano, L. M. Mallaber, P. J. Fay, and R. A. Bambara. 1991. Requirements for the catalysis of strand transfer synthesis by retroviral DNA polymerases. J. Biol. Chem. 266:13103-13109.
41. Butsch, M., and K. Boris-Lawrie. 2002. Destiny of unspliced retroviral RNA: ribosome and/or virion? J. Virol. 76:3089-3094. (Pubitemid 34224510)
42. Cabana, M., B. Clotet, and M. A. Martinez. 1999. Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors. J. Med. Virol. 59:480-490.
43. Calugi, G., F. Montella, C. Favalli, and A. Benedetto. 2006. Entire genome of a strain of human immunodeficiency virus type 1 with a deletion of nef that was recovered 20 years after primary infection: large pool of proviruses with deletions of env. J. Virol. 80:11892-11896. (Pubitemid 44788901)
44. Cameron, C. E., M. Ghosh, S. F. J. LeGrice, and S. J. Benkovic. 1997. Mutations in HIV reverse transcriptase which alter RNase H activity and decrease strand transfer efficiency are suppressed by HIV nucleocapsid protein. Proc. Natl. Acad. Sci. USA 94:6700-6705.
45. Certo, J. L., B. F. Shook, P. D. Yin, J. T. Snider, and W. S. Hu. 1998. Nonreciprocal pseudotyping: murine leukemia virus proteins cannot effi- ciently package spleen necrosis virus-based vector RNA. J. Virol. 72:5408-5413.
46. Champoux, J. J. 1993. Roles of ribonuclease H in reverse transcription, p. 103-117. In A. M. Skalka and S. P. Goff (ed.), Reverse transcriptase. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
47. Charpentier, C., T. Nora, O. Tenaillon, F. Clavel, and A. J. Hance. 2006. Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients. J. Virol. 80:2472-2482. (Pubitemid 43271553)
48. Chelico, L., P. Pham, P. Calabrese, and M. F. Goodman. 2006. APOBEC3G DNA deaminase acts processively 3′→35′ on single-stranded DNA. Nat. Struct. Mol. Biol. 13:392-399.
49. Chen, J., Q. Dang, D. Unutmaz, V. K. Pathak, F. Maldarelli, D. Powell, and W. S. Hu. 2005. Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor. J. Virol. 79:4140-4149.
50. Chen, J., D. Powell, and W. S. Hu. 2006. High frequency of genetic recombination is a common feature of primate lentivirus replication. J. Virol. 80:9651-9658.
51. Chen, J., T. D. Rhodes, and W. S. Hu. 2005. Comparison of the genetic recombination rates of human immunodeficiency virus type 1 in macrophages and T cells. J. Virol. 79:9337-9340.
52. Chen, P., W. Hubner, M. A. Spinelli, and B. K. Chen. 2007. Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J. Virol. 81:12582-12595. (Pubitemid 350085872)
53. Chen, Y., M. Balakrishnan, B. P. Roques, and R. A. Bambara. 2003. Steps of the acceptor invasion mechanism for HIV-1 minus strand strong stop transfer. J. Biol. Chem. 278:38368-38375.
54. Chin, M. P., J. Chen, O. A. Nikolaitchik, and W. S. Hu. 2007. Molecular determinants of HIV-1 intersubtype recombination potential. Virology 363:437-446.
55. Chin, M. P., T. D. Rhodes, J. Chen, W. Fu, and W. S. Hu. 2005. Identifi- cation of a major restriction in HIV-1 intersubtype recombination. Proc. Natl. Acad. Sci. USA 102:9002-9007.
56. Chiu, Y. L., and W. C. Greene. 2006. Multifaceted antiviral actions of APOBEC3 cytidine deaminases. Trends Immunol. 27:291-297.
57. Chohan, B., D. Lang, M. Sagar, B. Korber, L. Lavreys, B. Richardson, and J. Overbaugh. 2005. Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels. J. Virol. 79:6528-6531. (Pubitemid 40617257)
58. Chohan, B., L. Lavreys, S. M. Rainwater, and J. Overbaugh. 2005. Evidence for frequent reinfection with human immunodeficiency virus type 1 of a different subtype. J. Virol. 79:10701-10708. (Pubitemid 41098609)
59. Churchill, M. J., D. I. Rhodes, J. C. Learmont, J. S. Sullivan, S. L. Wesselingh, I. R. C. Cooke, N. J. Deacon, and P. R. Gorry. 2006. Longitudinal analysis of human immunodeficiency virus type 1 nef/long terminal repeat sequences in a cohort of long-term survivors infected from a single source. J. Virol. 80:1047-1052.
60. Clavel, F., M. D. Hoggan, R. L. Willey, K. Strebel, M. A. Martin, and R. Repaske. 1989. Genetic recombination of human immunodeficiency virus. J. Virol. 63:1455-1459. (Pubitemid 19061393)
61. Clever, J. L., and T. G. Parslow. 1997. Mutant human immunodeficiency virus type 1 genomes with defects in RNA dimerization or encapsidation. J. Virol. 71:3407-3414. (Pubitemid 27172349)
62. Clever, J. L., R. A. Taplitz, M. A. Lochrie, B. Polisky, and T. G. Parslow. 2000. A heterologous, high-affinity RNA ligand for human immunodefi- ciency virus Gag protein has RNA packaging activity. J. Virol. 74:541-546.
63. Clever, J. L., M. L. Wong, and T. G. Parslow. 1996. Requirements for kissing-loop-mediated dimerization of human immunodeficiency virus RNA. J. Virol. 70:5902-5908. (Pubitemid 26266802)
64. Coffin, J. 1996. Retroviridae: the viruses and their replication. In B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Fundamental virology, 3rd ed. Lippincott, Philadelphia, PA.
65. Coffin, J. 1982. Structure of retroviral genomes, p. 261-368. In R. Weiss, N. Teich, H. Varmus, and J. Coffin (ed.), RNA tumor viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
66. Coffin, J. M. 1986. Genetic variation in AIDS viruses. Cell 46:1-4.
67. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis and therapy. Science 267:483-489.
68. Coffin, J. M. 1979. Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses. J. Gen. Virol. 42:1-26.
69. Creighton, S., M.-M. Huang, H. Cai, N. Arnheim, and M. F. Goodman. 1992. Base mispair extension kinetics - binding of avian myeloblastosis reverse transcriptase to matched and mismatched base pair termini. J. Biol. Chem. 267:2633-2639.
70. Cullen, B. R. 2003. Nuclear mRNA export: insights from virology. Trends Biochem. Sci. 28:419-424.
71. Curlin, M. E., G. S. Gottlieb, S. E. Hawes, P. S. Sow, I. Ndoye, C. W. Critchlow, N. B. Kiviat, and J. I. Mullins. 2004. No evidence for recombination between HIV type 1 and HIV type 2 within the envelope region in dually seropositive individuals from Senegal. AIDS Res. Hum. Retrovir. 20:958-963.
72. Dang, Q., J. Chen, D. Unutmaz, J. M. Coffin, V. K. Pathak, D. Powell, V. N. KewalRamani, F. Maldarelli, and W. S. Hu. 2004. Nonrandom HIV-1 infection and double infection via direct and cell-mediated pathways. Proc. Natl. Acad. Sci. USA 101:632-637.
73. Dang, Q., and W. S. Hu. 2001. Effects of homology length in the repeat region on minus-strand DNA transfer and retroviral replication. J. Virol. 75:809-820.
74. Davis, W. R., S. Gabbara, D. Hupe, and J. A. Peliska. 1998. Actinomycin D inhibition of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase and nucleocapsid protein. Biochemistry 37:14213-14221.
75. Davis, W. R., J. Tomsho, S. Nikam, E. M. Cook, D. Somand, and J. A. Peliska. 2000. Inhibition of HIV-1 reverse transcriptase-catalyzed DNA strand transfer reactions by 4-chlorophenylhydrazone of mesoxalic acid. Biochemistry 39:14279-14291.
76. Delviks, K. A., and V. K. Pathak. 1999. Effect of distance between homologous sequences and 3′ homology on the frequency of retroviral reverse transcriptase template switching. J. Virol. 73:7923-7932.
77. Derebail, S. S., and J. J. DeStefano. 2004. Mechanistic analysis of pause site-dependent and -independent recombinogenic strand transfer from structurally diverse regions of the HIV genome. J. Biol. Chem. 279:47446-47454.
78. DeStefano, J. J., R. G. Buiser, L. M. Mallaber, T. W. Myers, R. A. Bambara, and P. J. Fay. 1991. Polymerization and RNase H activities of the reverse transcriptases from avian myeloblastosis, human immunodeficiency, and Moloney murine leukemia viruses are functionally uncoupled. J. Biol. Chem. 266:7423-7431.
79. DeStefano, J. J. 1994. Kinetic analysis of the catalysis of strand transfer from internal regions of heteropolymeric RNA templates by human immunodeficiency virus reverse transcriptase. J. Mol. Biol. 243:558-567.
80. DeStefano, J. J., A. Raja, and J. V. Cristofaro. 2000. In vitro strand transfer from broken RNAs results in mismatch but not frameshift mutations. Virology 276:7-15.
81. DeZazzo, J. D., J. M. Scott, and M. J. Imperiale. 1992. Relative roles of signals upstream of AAUAAA and promoter proximity in regulation of human immunodeficiency virus type 1 mRNA 3′ end formation. Mol. Cell. Biol. 12:5555-5562.
82. Diamond, T. L., M. Roshal, V. K. Jamburuthugoda, H. M. Reynolds, A. R. Merriam, K. Y. Lee, M. Balakrishnan, R. A. Bambara, V. Planelles, S. Dewhurst, and B. Kim. 2004. Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase. J. Biol. Chem. 279:51545-51553.
83. Domingo, E., V. Martin, C. Perales, A. Grande-Perez, J. Garcia-Arriaza, and A. Arias. 2006. Viruses as quasispecies: biological implications. Curr. Top. Microbiol. Immunol. 299:51-82.
84. Doria-Rose, N. A., and V. M. Vogt. 1998. In vivo selection of Rous sarcoma virus mutants with randomized sequences in the packaging signal. J. Virol. 72:8073-8082.
85. D'Souza, V., and M. F. Summers. 2005. How retroviruses select their genomes. Nat. Rev. Microbiol. 3:643-655.
86. Duch, M., M. L. Carrasco, T. Jespersen, L. Aagaard, and F. S. Pedersen. 2004. An RNA secondary structure bias for non-homologous reverse transcriptase-mediated deletions in vivo. Nucleic Acids Res. 32:2039-2048. (Pubitemid 38842544)
87. Duggal, N. K., L. Goo, S. R. King, and A. Telesnitsky. 2007. Effects of identity minimization on Moloney murine leukemia virus template recognition and frequent tertiary template-directed insertions during nonhomologous recombination. J. Virol. 81:12156-12168.
88. Dvorin, J. D., P. Bell, G. G. Maul, M. Yamashita, M. Emerman, and M. H. Malim. 2002. Reassessment of the roles of integrase and the central DNA flap in human immunodeficiency virus type 1 nuclear import. J. Virol. 76:12087-12096. (Pubitemid 35304308)
89. Dykes, C., M. Balakrishnan, V. Planelles, Y. Zhu, R. A. Bambara, and L. M. Demeter. 2004. Identification of a preferred region for recombination and mutation in HIV-1 gag. Virology 326:262-279. (Pubitemid 39078258)
90. Emiliani, S., C. Van Lint, W. Fischle, P. Paras, Jr., M. Ott, J. Brady, and E. Verdin. 1996. A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency. Proc. Natl. Acad. Sci. USA 93:6377-6381.
91. Fackler, O. T., A. Alcover, and O. Schwartz. 2007. Modulation of the immunological synapse: a key to HIV-1 pathogenesis? Nat. Rev. Immunol. 7:310-317.
92. Fan, J., M. Negroni, and D. L. Robertson. 2007. The distribution of HIV-1 recombination breakpoints. Infect. Genet. Evol. 7:717-723.
93. Fang, G., B. Weiser, C. Kuiken, S. M. Philpott, S. Rowland-Jones, F. Plummer, J. Kimani, B. Shi, R. Kaul, J. Bwayo, O. Anzala, and H. Burger. 2004. Recombination following superinfection by HIV-1. AIDS 18:153-159.
94. Fassati, A., and S. P. Goff. 2001. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J. Virol. 75:3626-3635. (Pubitemid 32246372)
95. Flynn, J. A. 2005. Retroviral genomic RNA dimer partner selection. University of Michigan, Ann Arbor.
96. Flynn, J. A., W. An, S. R. King, and A. Telesnitsky. 2004. Nonrandom dimerization of murine leukemia virus genomic RNAs. J. Virol. 78:12129-12139.
97. Flynn, J. A., and A. Telesnitsky. 2006. Two distinct Moloney murine leukemia virus RNAs produced from a single locus dimerize at random. Virology 344:391-400.
98. Fu, T.-B., and J. Taylor. 1992. When retroviral reverse transcriptases reach the end of their RNA templates. J. Virol. 66:4271-4278.
99. Fuentes, G. M., C. Palaniappan, P. J. Fay, and R. A. Bambara. 1996. Strand displacement synthesis in the central polypurine tract region of HIV-1 promotes DNA to DNA strand transfer recombination. J. Biol. Chem. 271:29605-29611.
100. Fultz, P., L. You, Q. Wei, and M. Girard. 1997. Human immunodeficiency virus type 1 intersubtype (B/E) recombination in a superinfected chimpanzee. J. Virol. 71:7990-7995. (Pubitemid 27391754)
101. Furfine, E. S., and J. E. Reardon. 1991. Reverse transcriptase RNase H from the human immunodeficiency virus. Relationship of the DNA polymerase and RNA hydrolysis activities. J. Biol. Chem. 266:406-412.
102. Galetto, R., V. Giacomoni, M. Veron, and M. Negroni. 2006. Dissection of a circumscribed recombination hot spot in HIV-1 after a single infectious cycle. J. Biol. Chem. 281:2711-2720.
103. Gao, F., E. Bailes, D. L. Robertson, Y. Chen, C. M. Rodenburg, S. F. Michael, L. B. Cummins, L. O. Arthur, M. Peeters, G. M. Shaw, P. M. Sharp, and B. H. Hahn. 1999. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397:436-441. (Pubitemid 29078911)
104. Gao, L., M. Balakrishnan, B. P. Roques, and R. A. Bambara. 2007. Insights into the multiple roles of pausing in HIV-1 reverse transcriptase-promoted strand transfers. J. Biol. Chem. 282:6222-6231.
105. Gao, L., M. N. Hanson, M. Balakrishnan, P. L. Boyer, B. P. Roques, S. H. Hughes, B. Kim, and R. A. Bambara. 2008. Apparent defects in processive DNA synthesis, strand transfer, and primer elongation of Met-184 mutants of HIV-1 reverse transcriptase derive solely from a dNTP utilization defect. J. Biol. Chem. 283:9196-9205.
106. Garcés, J., and R. Wittek. 1991. Reverse-transcriptase-associated RNaseH activity mediates template switching during reverse transcription in vitro. Proc. R. Soc. Lond. B 243:235-239.
107. Garcia-Lerma, J. G., and W. Heneine. 2001. Resistance of human immunodeficiency virus type 1 to reverse transcriptase and protease inhibitors: genotypic and phenotypic testing. J. Clin. Virol. 21:197-212.
108. Gelderblom, H. C., D. N. Vatakis, S. A. Burke, S. D. Lawrie, G. C. Bristol, and D. N. Levy. 2008. Viral complementation allows HIV-1 replication without integration. Retrovirology 5:60.
109. Gifford, R. J., S. Y. Rhee, N. Eriksson, T. F. Liu, M. Kiuchi, A. K. Das, and R. W. Shafer. 2008. Sequence editing by apolipoprotein B RNA-editing catalytic component-B and epidemiological surveillance of transmitted HIV-1 drug resistance. AIDS 22:717-725.
110. Gilboa, E., S. W. Mitra, S. Goff, and D. Baltimore. 1979. A detailed model of reverse transcription and tests of crucial aspects. Cell 18:93-100. (Pubitemid 10228240)
111. Goff, S. P. 2007. Host factors exploited by retroviruses. Nat. Rev. Microbiol. 5:253-263.
112. Gopalakrishnan, V., J. A. Peliska, and S. J. Benkovic. 1992. Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities. Proc. Natl. Acad. Sci. USA 89:10763-10767.
113. Graci, J. D., and C. E. Cameron. 2002. Quasispecies, error catastrophe, and the antiviral activity of ribavirin. Virology 298:175-180.
114. Gratton, S., R. Cheynier, M. J. Dumaurier, E. Oksenhendler, and S. Wain- Hobson. 2000. Highly restricted spread of HIV-1 and multiply infected cells within splenic germinal centers. Proc. Natl. Acad. Sci. USA 97:14566-14571.
115. Greatorex, J., and A. Lever. 1998. Retroviral RNA dimer linkage. J. Gen. Virol. 79:2877-2882.
116. Griffin, S. D., J. F. Allen, and A. M. Lever. 2001. The major human immunodeficiency virus type 2 (HIV-2) packaging signal is present on all HIV-2 RNA species: cotranslational RNA encapsidation and limitation of Gag protein confer specificity. J. Virol. 75:12058-12069.
117. Groenink, M., A. C. Andeweg, R. A. Fouchier, S. Broersen, R. C. van der Jagt, H. Schuitemaker, R. E. de Goede, M. L. Bosch, H. G. Huisman, and M. Tersmette. 1992. Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain. J. Virol. 66:6175-6180.
118. Gunthard, H. F., A. J. Leigh-Brown, R. T. D'Aquila, V. A. Johnson, D. R. Kuritzkes, D. D. Richman, and J. K. Wong. 1999. Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1. J. Virol. 259:154-165.
119. Guo, J., L. E. Henderson, J. Bess, B. Kane, and J. G. Levin. 1997. Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA. J. Virol. 71:5178-5188. (Pubitemid 27258190)
120. Hajjar, A. M., and M. L. Linial. 1993. A model system for nonhomologous recombination between retroviral and cellular RNA. J. Virol. 67:3845-3853.
121. Hajjar, A. M., and M. L. Linial. 1993. Characterization of a unique retroviral recombinant containing 7S L sequences. J. Virol. 67:7677-7679.
122. Han, K., J. Lee, T. J. Meyer, P. Remedios, L. Goodwin, and M. A. Batzer. 2008. L1 recombination-associated deletions generate human genomic variation. Proc. Natl. Acad. Sci. USA 105:19366-19371.
123. Han, Y., M. Wind-Rotolo, H. C. Yang, J. D. Siliciano, and R. F. Siliciano. 2007. Experimental approaches to the study of HIV-1 latency. Nat. Rev. Microbiol. 5:95-106.
124. Hanson, M. N., M. Balakrishnan, B. P. Roques, and R. A. Bambara. 2005. Effects of donor and acceptor RNA structures on the mechanism of strand transfer by HIV-1 reverse transcriptase. J. Mol. Biol. 353:772-787.
125. Hanson, M. N., M. Balakrishnan, B. P. Roques, and R. A. Bambara. 2006. Evidence that creation of invasion sites determines the rate of strand transfer mediated by HIV-1 reverse transcriptase. J. Mol. Biol. 363:878-890.
126. Harrison, G. P., M. S. Mayo, E. Hunter, and A. M. L. Lever. 1998. Pausing of reverse transcriptase on retroviral RNA templates is influenced by secondary structures both 5′ and 3′ of the catalytic site. Nucleic Acids Res. 26:3433-3442.
127. Heard, J. M., and O. Danos. 1991. An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor. J. Virol. 65:4026-4032.
128. Heath, M. J., and J. J. Destefano. 2005. A complementary single-stranded docking site is required for enhancement of strand exchange by human immunodeficiency virus nucleocapsid protein on substrates that model viral recombination. Biochemistry 44:3915-3925.
129. Heeney, J. L., A. G. Dalgleish, and R. A. Weiss. 2006. Origins of HIV and the evolution of resistance to AIDS. Science 313:462-466. (Pubitemid 44148444)
130. Helga-Maria, C., M.-L. Hammarskjold, and D. Rekosh. 1999. An intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type 1 genomic RNA. J. Virol. 73:4127-4135. (Pubitemid 29189858)
131. Hibbert, C. S., J. Mirro, and A. Rein. 2004. mRNA molecules containing murine leukemia virus packaging signals are encapsidated as dimers. J. Virol. 78:10927-10938.
132. Hizi, A., R. Tal, M. Shaharabany, and S. Loya. 1991. Catalytic properties of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2. J. Biol. Chem. 266:6230-6239.
133. Hu, W.-S., E. H. Bowman, K. A. Delviks, and V. K. Pathak. 1997. Homologous recombination occurs in a distinct retroviral subpopulation and exhibits high negative interference. J. Virol. 71:6028-6036.
134. Hu, W.-S., and H. M. Temin. 1992. Effect of gamma radiation on retroviral recombination. J. Virol. 66:4457-4463.
135. Hu, W.-S., and H. M. Temin. 1990. Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc. Natl. Acad. Sci. USA 87:1556-1560.
136. Hu, W.-S., and H. M. Temin. 1990. Retroviral recombination and reverse transcription. Science 250:1227-1233.
137. Huang, H., R. Chopra, G. L. Verdine, and S. C. Harrison. 1998. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 282:1669-1675. (Pubitemid 28549275)
138. Huang, H., S. C. Harrison, and G. L. Verdine. 2000. Trapping of a catalytic HIV reverse transcriptase*template:primer complex through a disulfide bond. Chem. Biol. 7:355-364.
139. gag protein for efficient induction of disease. J. Virol. 69:60-68.
140. Hughes, J. F., and J. M. Coffin. 2005. Human endogenous retroviral elements as indicators of ectopic recombination events in the primate genome. Genetics 171:1183-1194.
141. Huigen, M. C., L. de Graaf, D. Eggink, R. Schuurman, V. Muller, A. Stamp, D. K. Stammers, C. A. Boucher, and M. Nijhuis. 2007. Evolution of a novel 5-amino-acid insertion in the beta3-beta4 loop of HIV-1 reverse transcriptase. Virology 364:395-406.
142. Hwang, C. K., E. S. Svarovskaia, and V. K. Pathak. 2001. Dynamic copy choice: steady state between murine leukemia virus polymerase and polymerase- dependent RNase H activity determines frequency of in vivo template switching. Proc. Natl. Acad. Sci. USA 98:12209-12214.
143. Iwabu, Y., H. Mizuta, M. Kawase, M. Kameoka, T. Goto, and K. Ikuta. 2008. Superinfection of defective human immunodeficiency virus type 1 with different subtypes of wild-type virus efficiently produces infectious variants with the initial viral phenotypes by complementation followed by recombination. Microbes Infect. 10:504-513.
144. Iwatani, Y., D. S. Chan, F. Wang, K. S. Maynard, W. Sugiura, A. M. Gronenborn, I. Rouzina, M. C. Williams, K. Musier-Forsyth, and J. G. Levin. 2007. Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. Nucleic Acids Res. 35:7096-7108.
145. Jacobo-Molina, A., J. Ding, R. G. Nanni, A. D. Clark, X. Lu, C. Tantillo, R. L. Williams, G. Kamer, A. L. Ferris, P. Clark, A. Hizi, S. H. Hughes, and E. Arnold. 1993. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc. Natl. Acad. Sci. USA 90:6320-6324.
146. Jamburuthugoda, V. K., D. Guo, J. E. Wedekind, and B. Kim. 2005. Kinetic evidence for interaction of human immunodeficiency virus type 1 reverse transcriptase with the 3′-OH of the incoming dTTP substrate. Biochemistry 44:10635-10643.
147. Jamburuthugoda, V. K., J. M. Santos-Velazquez, M. Skasko, D. J. Operario, V. Purohit, P. Chugh, E. A. Szymanski, J. E. Wedekind, R. A. Bambara, and B. Kim. 2008. Reduced dNTP binding affinity of 3TC-resistant M184I HIV-1 reverse transcriptase variants responsible for viral infection failure in macrophage. J. Biol. Chem. 283:9206-9216.
148. Jetzt, A. E., H. Yu, G. J. Klarmann, Y. Ron, B. D. Preston, and J. P. Dougherty. 2000. High rate of recombination throughout the human immunodeficiency virus type 1 genome. J. Virol. 74:1234-1240. (Pubitemid 30044072)
149. Jin, X., A. Brooks, H. Chen, R. Bennett, R. Reichman, and H. Smith. 2005. APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia. J. Virol. 79:11513-11516. (Pubitemid 41170693)
150. Jolly, C., K. Kashefi, M. Hollinshead, and Q. J. Sattentau. 2004. HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J. Exp. Med. 199:283-293.
151. Jones, J. S., R. W. Allan, and H. M. Temin. 1993. Alteration of location of dimer linkage sequence in retroviral RNA: little effect on replication or homologous recombination. J. Virol. 67:3151-3158.
152. Jones, J. S., R. W. Allan, and H. M. Temin. 1994. One retroviral RNA is sufficient for synthesis of viral DNA. J. Virol. 68:207-216. (Pubitemid 24974623)
153. Jones, K. L., S. Sonza, and J. Mak. 2008. Primary T-lymphocytes rescue the replication of HIV-1 DIS RNA mutants in part by facilitating reverse transcription. Nucleic Acids Res. 36:1578-1588.
154. Julias, J. G., A. L. Ferris, P. L. Boyer, and S. H. Hughes. 2001. Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase. J. Virol. 75:6537-6546.
155. Julias, J. G., D. Hash, and V. K. Pathak. 1995. E-vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy. J. Virol. 69:6839-6846.
156. Jung, A., R. Maier, J.-P. Vartanian, R. Bocharov, V. Jung, U. Fischer, E. Meese, S. Wain-Hobson, and A. Meyerhans. 2002. Multiply infected spleen cells in HIV patients. Nature 48:144. (Pubitemid 34773761)
157. Junghans, R. P., L. R. Boone, and A. M. Skalka. 1982. Products of reverse
158. Junghans, R. P., L. R. Boone, and A. M. Skalka. 1982. Retroviral DNA H structures: displacement-assimilation model of recombination. Cell 30:53-62.
159. Kati, W. M., K. A. Johnson, L. F. Jerva, and K. S. Anderson. 1992. Mechanism and fidelity of HIV reverse transcriptase. J. Biol. Chem. 267:25988-25997.
160. Katz, R. A., and A. M. Skalka. 1990. Generation of diversity in retroviruses. Annu. Rev. Genet. 24:409-445.
161. Kaye, J. F., and A. M. L. Lever. 1998. Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation. J. Virol. 72:5877-5884.
162. Keele, B. F., E. E. Giorgi, J. F. Salazar-Gonzalez, J. M. Decker, K. T. Pham, M. G. Salazar, C. Sun, T. Grayson, S. Wang, H. Li, X. Wei, C. Jiang, J. L. Kirchherr, F. Gao, J. A. Anderson, L. H. Ping, R. Swanstrom, G. D. Tomaras, W. A. Blattner, P. A. Goepfert, J. M. Kilby, M. S. Saag, E. L. Delwart, M. P. Busch, M. S. Cohen, D. C. Montefiori, B. F. Haynes, B. Gaschen, G. S. Athreya, H. Y. Lee, N. Wood, C. Seoighe, A. S. Perelson, T. Bhattacharya, B. T. Korber, B. H. Hahn, and G. M. Shaw. 2008. Identifi- cation and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. USA 105:7552-7557.
163. Kellam, P., and B. A. Larder. 1995. Retroviral recombination can lead to linkage of reverse transcriptase mutations that confer increased zidovudine resistance. J. Virol. 69:669-674.
164. Kelleher, A. D., C. Long, E. C. Holmes, R. L. Allen, J. Wilson, C. Conlon, C. Workman, S. Shaunak, K. Olson, P. Goulder, C. Brander, G. Ogg, J. S. Sullivan, W. Dyer, I. Jones, A. J. McMichael, S. Rowland-Jones, and R. E. Phillips. 2001. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J. Exp. Med. 193:375-386.
165. Kharytonchyk, S. A., A. I. Kireyeva, A. B. Osipovich, and I. K. Fomin. 2005. Evidence for preferential copackaging of Moloney murine leukemia virus genomic RNAs transcribed in the same chromosomal site. Retrovirology 2:3.
166. King, S. R., N. K. Duggal, C. B. Ndongmo, C. Pacut, and A. Telesnitsky. 2008. Pseudodiploid genome organization aids full-length human immunodeficiency virus type 1 DNA synthesis. J. Virol. 82:2376-2384.
167. Kirchhoff, F., H. W. Kestler III, and R. C. Desrosiers. 1994. Upstream U3 sequences in simian immunodeficiency virus are selectively deleted in vivo in the absence of an intact nef gene. J. Virol. 68:2031-2037. (Pubitemid 24065780)
168. Kishi, M., K. Tokunaga, Y. H. Zheng, M. K. Bahmani, M. Kakinuma, M. Nonoyama, P. K. Lai, and K. Ikuta. 1995. Superinfection of a defective human immunodeficiency virus type 1 provirus-carrying T cell clone with vif or vpu mutants gives cytopathic virus particles by homologous recombination. AIDS Res. Hum. Retrovir. 11:45-53.
169. Kishi, M., Y. H. Zheng, M. K. Bahmani, K. Tokunaga, H. Takahashi, M. Kakinuma, P. K. Lai, M. Nonoyama, R. B. Luftig, and K. Ikuta. 1995. Naturally occurring accessory gene mutations lead to persistent human immunodeficiency virus type 1 infection of CD4-positive T cells. J. Virol. 69:7507-7518.
170. Kitrinos, K. M., N. G. Hoffman, J. A. E. Nelson, and R. Swanstrom. 2003. Turnover of env variable region 1 and 2 genotypes in subjects with late-stage human immunodeficiency virus type 1 infection. J. Virol. 77:6811-6822.
171. Kitrinos, K. M., J. A. E. Nelson, W. Resch, and R. Swanstrom. 2005. Effect of a protease inhibitor-induced genetic bottleneck on human immunodefi- ciency virus type 1 env gene populations. J. Virol. 79:10627-10637.
172. Klarmann, G. J., H. Yu, X. Chen, J. P. Dougherty, and B. D. Preston. 1997. Discontinuous plus-strand DNA synthesis in human immunodeficiency virus type 1-infected cells and in a partially reconstituted cell-free system. J. Virol. 71:9259-9269.
173. Kol, N., M. Gladnikoff, D. Barlam, R. Z. Shneck, A. Rein, and I. Rousso. 2006. Mechanical properties of murine leukemia virus particles: effect of maturation. Biophys. J. 91:767-774.
174. Konstantinova, P., P. de Haan, A. T. Das, and B. Berkhout. 2006. Hairpininduced tRNA-mediated (HITME) recombination in HIV-1. Nucleic Acids Res. 34:2206-2218. (Pubitemid 43985659)
175. Kozaczynska, K., M. Cornelissen, P. Reiss, F. Zorgdrager, and A. C. van der Kuyl. 2007. HIV-1 sequence evolution in vivo after superinfection with three viral strains. Retrovirology 4:59. (Pubitemid 47593395)
176. Kulpa, D., R. Topping, and A. Telesnitsky. 1997. Determination of the site of first strand transfer during Moloney murine leukemia virus reverse transcription and identification of strand transfer-associated reverse transcriptase errors. EMBO J. 16:856-865. (Pubitemid 27089532)
177. Kumar, M., B. Keller, N. Makalou, and R. E. Sutton. 2001. Systematic determination of the packaging limit of lentiviral vectors. Hum. Gene Ther. 12:1893-1905.
178. Kuwata, T., Y. Miyazaki, T. Igarashi, J. Takehisa, and M. Hayami. 1997. The rapid spread of recombinants during a natural in vitro infection with two human immunodeficiency virus type 1 strains. J. Virol. 71:7088-7091. (Pubitemid 27355376)
179. Laham-Karam, N., and E. Bacharach. 2007. Transduction of human immunodeficiency virus type 1 vectors lacking encapsidation and dimerization signals. J. Virol. 81:10687-10698. (Pubitemid 47463342)
180. Laird, M. E., T. Igarashi, M. A. Martin, and R. C. Desrosiers. 2008. Importance of the V1/V2 loop region of simian-human immunodeficiency virus envelope glycoprotein gp120 in determining the strain specificity of the neutralizing antibody response. J. Virol. 82:11054-11065.
181. Lama, J. 2003. The physiological relevance of CD4 receptor down-modulation during HIV infection. Curr. HIV Res. 1:167-184.
182. Lanciault, C., and J. J. Champoux. 2006. Pausing during reverse transcription increases the rate of retroviral recombination. J. Virol. 80:2483-2494. (Pubitemid 43271554)
183. Lapadat-Tapolsky, M., C. Gabus, M. Rau, and J.-L. Darlix. 1997. Possible roles of HIV-1 nucleocapsid protein in the specificity of proviral DNA synthesis and in its variability. J. Mol. Biol. 268:250-260.
184. Lefeuvre, P., J. M. Lett., B. Reynaud, and D. P. Martin. 2007. Avoidance of protein fold disruption in natural virus recombinants. PLoS Pathog. 3:e181. (Pubitemid 350291612)
185. Leitner, T., and J. Albert. 1999. The molecular clock of HIV-1 unveiled through analysis of a known transmission history. Proc. Natl. Acad. Sci. USA 96:10752-10757.
186. Lever, A. M. 2007. HIV-1 RNA packaging. Adv. Pharmacol. 55:1-32.
187. Levin, J. G., P. M. Grimley, J. M. Ramseur, and I. K. Berezesky. 1974. Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. J. Virol. 14:152-161.
188. Levin, J. G., J. Guo, I. Rouzina, and K. Musier-Forsyth. 2005. Nucleic acid chaperone activity of HIV-1 nucleocapsid protein: critical role in reverse transcription and molecular mechanism. Prog. Nucleic Acid Res. Mol. Biol. 80:217-286.
189. Levy, D. N., G. M. Aldrovandi, O. Kutsch, and G. M. Shaw. 2004. Dynamics of HIV-1 recombination in its natural target cells. Proc. Natl. Acad. Sci. USA 101:4204-4209.
190. Li, T., and J. Zhang. 2001. Retroviral recombination is temperature dependent. J. Gen. Virol. 82:1359-1364.
191. Li, Y., and S. Carpenter. 2001. cis-acting sequences may contribute to size variation in the surface glycoprotein of bovine immunodeficiency virus. J. Gen. Virol. 82:2989-2998.
192. Liu, S., E. A. Abbondanzieri, J. W. Rausch, S. F. Le Grice, and X. Zhuang. 2008. Slide into action: dynamic shuttling of HIV reverse transcriptase on nucleic acid substrates. Science 322:1092-1097.
193. Liu, Y., M. E. Curlin, K. Diem, H. Zhao, A. K. Ghosh, H. Zhu, A. S. Woodward, J. Maenza, C. E. Stevens, J. Stekler, A. C. Collier, I. Genowati, W. Deng, R. Zioni, L. Corey, T. Zhu, and J. I. Mullins. 2008. Env length and N-linked glycosylation following transmission of human immunodeficiency virus type 1 subtype B viruses. Virology 374:229-233.
194. Lobato, R. L., E. Y. Kim, R. M. Kagan, and T. C. Merigan. 2002. Genotypic and phenotypic analysis of a novel 15-base insertion occurring between codons 69 and 70 of HIV type 1 reverse transcriptase. AIDS Res. Hum. Retrovir. 18:733-736.
195. Loeb, L. A., J. M. Essigmann, F. Kazazi, J. Zhang, K. D. Rose, and J. I. Mullins. 1999. Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc. Natl. Acad. Sci. USA 96:1492-1497.
196. Luo, G. X., and J. Taylor. 1990. Template switching by reverse transcriptase during DNA synthesis. J. Virol. 64:4321-4328. (Pubitemid 20279842)
197. Magiorkinis, G., D. Paraskevis, A. M. Vandamme, E. Magiorkinis, V. Sypsa, and A. Hatzakis. 2003. In vivo characteristics of human immunode- ficiency virus type 1 intersubtype recombination: determination of hot spots and correlation with sequence similarity. J. Gen. Virol. 84:2715-2722.
198. Malim, M. H., and M. Emerman. 2001. HIV-1 sequence variation: drift, shift, and attenuation. Cell 104:469-472.
199. Marchand, B., and M. Gotte. 2004. Impact of the translocational equilibrium of HIV-1 reverse transcriptase on the efficiency of mismatch extensions and the excision of mispaired nucleotides. Int. J. Biochem. Cell Biol. 36:1823-1835.
200. Mark-Danieli, M., N. Laham, M. Kenan-Eichler, A. Castiel, D. Melamed, M. Landau, N. M. Bouvier, M. J. Evans, and E. Bacharach. 2005. Single point mutations in the zinc finger motifs of the human immunodeficiency virus type 1 nucleocapsid alter RNA binding specificities of the Gag protein and enhance packaging and infectivity. J. Virol. 79:7756-7767. (Pubitemid 40756809)
201. Marlowe, N., T. Flys, J. Hackett, Jr., M. Schumaker, J. B. Jackson, and S. H. Eshleman. 2004. Analysis of insertions and deletions in the gag p6 region of diverse HIV type 1 strains. AIDS Res. Hum. Retrovir. 20:1119-1125.
202. Marr, S. F., and A. Telesnitsky. 2003. Mismatch extension during strong stop strand transfer and minimal homology requirements for replicative template switching during Moloney murine leukemia virus replication. J. Mol. Biol. 330:657-674.
203. Martin, G. S. 2004. The road to Src. Oncogene 23:7910-7917.
204. Martinez-Picado, J., J. G. Prado, E. E. Fry, K. Pfafferott, A. Leslie, S. Chetty, C. Thobakgale, I. Honeyborne, H. Crawford, P. Matthews, T. Pillay, C. Rousseau, J. I. Mullins, C. Brander, B. D. Walker, D. I. Stuart, P. Kiepiela, and P. Goulder. 2006. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J. Virol. 80:3617-3623.
205. Mbisa, J. L., R. Barr, J. A. Thomas, N. Vandegraaff, I. J. Dorweiler, E. S. Svarovskaia, W. L. Brown, L. M. Mansky, R. J. Gorelick, R. S. Harris, A. Engelman, and V. K. Pathak. 2007. Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plusstrand DNA transfer and integration. J. Virol. 81:7099-7110.
206. McCutchan, F. E. 1999. Global diversity of HIV, p. 41-101. In K. A. Crandall (ed.), The evolution of HIV. Johns Hopkins University Press, Baltimore, MD.
207. McCutchan, F. E. 2006. Global epidemiology of HIV. J. Med. Virol. 78(Suppl. 1):S7-S12.
208. McCutchan, F. E. 2000. Understanding the genetic diversity of HIV-1. AIDS 14:S31-S44.
209. McCutchan, F. E., M. Hoelscher, S. Tovanabutra, S. Piyasirisilp, E. Sanders- Buell, G. Ramos, L. Jagodzinski, V. Polonis, L. Maboko, D. Mmbando, O. Hoffmann, G. Riedner, F. von Sonnenburg, M. Robb, and D. L. Birx. 2005. In-depth analysis of a heterosexually acquired human immunodefi- ciency virus type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfection. J. Virol. 79:11693-11704.
210. McGrath, K. M., N. G. Hoffman, W. Resch, J. A. E. Nelson, and R. Swanstrom. 2001. Using HIV-1 sequence variability to explore virus biology. Virus Res. 76:137-160.
211. Mikkelsen, J. G., and F. S. Pedersen. 2000. Genetic reassortment and patch repair by recombination in retroviruses. J. Biomed. Sci. 7:77-99.
212. Mild, M., J. Esbjornsson, E. M. Fenyo, and P. Medstrand. 2007. Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch. J. Virol. 81:3369-3376. (Pubitemid 46456646)
213. Miles, B. D., and H. L. Robinson. 1985. High-frequency transduction of c-erbB in avian-leukosis virus-induced erythroblastosis. J. Virol. 54:295-303.
214. Moncany, M. L., K. Dalet, and P. R. Courtois. 2006. Identification of conserved lentiviral sequences as landmarks of genomic flexibility. C. R. Biol. 329:751-764.
215. Moore, M. D., W. Fu, O. Nikolaitchik, J. Chen, R. G. Ptak, and W. S. Hu. 2007. Dimer initiation signal of human immunodeficiency virus type 1: its role in partner selection during RNA copackaging and its effects on recombination. J. Virol. 81:4002-4011.
216. Moore, M. D., and W. S. Hu. 2009. HIV-1 RNA dimerization: it takes two to tango. AIDS Rev. 11:91-102.
217. Motomura, K., J. Chen, and W. S. Hu. 2008. Genetic recombination between human immunodeficiency virus type 1 (HIV-1) and HIV-2, two distinct human lentiviruses. J. Virol. 82:1923-1933.
218. Mouland, A. J., J. Mercier, M. Luo, L. Bernier, L. DesGroseillers, and E. A. Cohen. 2000. The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation. J. Virol. 74:5441-5451.
219. Moumen, A., L. Polomack, T. Unge, M. Veron, H. Buc, and M. Negroni. 2003. Evidence for a mechanism of recombination during reverse transcription dependent on the structure of the acceptor RNA. J. Biol. Chem. 278:15973-15982.
220. Moutouh, L., J. Corbeil, and D. D. Richman. 1996. Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure. Proc. Natl. Acad. Sci. USA 93:6106-6111.
221. Mukherjee, S., H. L. Lee, Y. Ron, and J. P. Dougherty. 2006. Proviral progeny of heterodimeric virions reveal a high crossover rate for human immunodeficiency virus type 2. J. Virol. 80:12402-12407. (Pubitemid 44904392)
222. Mulder, L. C., A. Harari, and V. Simon. 2008. Cytidine deamination induced HIV-1 drug resistance. Proc. Natl. Acad. Sci. USA 105:5501-5506.
223. Mullins, J. I., and M. A. Jensen. 2006. Evolutionary dynamics of HIV-1 and the control of AIDS. Curr. Top. Microbiol. Immunol. 299:171-192.
224. Negroni, M., and H. Buc. 2000. Copy-choice recombination by reverse transcriptases: reshuffling of genetic markers mediated by RNA chaperones. Proc. Natl. Acad. Sci. USA 97:6385-6390.
225. Negroni, M., and H. Buc. 2001. Mechanisms of retroviral recombination. Annu. Rev. Genet. 35:275-302.
226. Negroni, M., and H. Buc. 1999. Recombination during reverse transcription: an evaluation of the role of the nucleocapsid protein. J. Mol. Biol. 286:15-31.
227. Negroni, M., and H. Buc. 2001. Retroviral recombination: what drives the switch? Nat. Rev. Mol. Cell Biol. 2:151-155.
228. Negroni, M., M. Ricchetti, P. Nouvel, and H. Buc. 1995. Homologous recombination promoted by reverse transcriptase during copying of two distinct RNA templates. Proc. Natl. Acad. Sci. USA 92:6971-6975.
229. Neil, J. C., R. Fulton, M. Rigby, and M. Stewart. 1991. Feline leukaemia virus: generation of pathogenic and oncogenic variants. Curr. Top. Microbiol. Immunol. 171:67-93.
230. Nethe, M., B. Berkhout, and A. C. van der Kuyl. 2005. Retroviral superinfection resistance. Retrovirology 2:52.
231. Nikolaitchik, O., T. D. Rhodes, D. Ott, and W.-S. Hu. 2006. Effects of mutations in the human immunodeficiency virus type 1 gag gene on RNA packaging and recombination. J. Virol. 80:4691-4697.
232. Nikolenko, G. N., K. A. Delviks-Frankenberry, S. Palmer, F. Maldarelli, M. J. Fivash, Jr., J. M. Coffin, and V. K. Pathak. 2007. Mutations in the connection domain of HIV-1 reverse transcriptase increase 3′-azido- 3′-deoxythymidine resistance. Proc. Natl. Acad. Sci. USA 104:317-322.
233. Nikolenko, G. N., S. Palmer, F. Maldarelli, J. W. Mellors, J. M. Coffin, and V. K. Pathak. 2005. Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: balance between RNase H activity and nucleotide excision. Proc. Natl. Acad. Sci. USA 102:2093-2098.
234. Nikolenko, G. N., E. S. Svarovskaia, K. A. Delviks, and V. K. Pathak. 2004. Antiretroviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase increase template-switching frequency. J. Virol. 78:8761-8770. (Pubitemid 39025141)
235. Nora, T., C. Charpentier, O. Tenaillon, C. Hoede, F. Clavel, and A. J. Hance. 2007. Contribution of recombination to the evolution of human immunodeficiency viruses expressing resistance to antiretroviral treatment. J. Virol. 81:7620-7628. (Pubitemid 47047847)
236. Nowarski, R., E. Britan-Rosich, T. Shiloach, and M. Kotler. 2008. Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase. Nat. Struct. Mol. Biol. 15:1059-1066.
237. O'Brien, W. A., A. Namazi, H. Kalhor, S. H. Mao, J. A. Zack, and I. S. Chen. 1994. Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J. Virol. 68:1258-1263.
238. Ogert, R. A., M. K. Lee, W. Ross, A. Buckler-White, M. A. Martin, and M. W. Cho. 2001. N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism. J. Virol. 75:5998-6006.
239. Olsen, J. C., C. Bova-Hill, D. P. Grandgenett, T. P. Quinn, J. P. Manfredi, and R. Swanstrom. 1990. Rearrangements in unintegrated retroviral DNA are complex and are the result of multiple genetic determinants. J. Virol. 64:5475-5484.
240. Onafuwa, A., W. An, N. D. Robson, and A. Telesnitsky. 2003. Human immunodeficiency virus type 1 genetic recombination is more frequent than that of Moloney murine leukemia virus despite similar template switching rates. J. Virol. 77:4577-4587. (Pubitemid 36402807)
241. Operario, D. J., M. Balakrishnan, R. A. Bambara, and B. Kim. 2006. Reduced dNTP interaction of human immunodeficiency virus type 1 reverse transcriptase promotes strand transfer. J. Biol. Chem. 281:32113-32121.
242. Overbaugh, J., and L. M. Rudensky. 1992. Alterations in potential sites for glycosylation predominate during evolution of the simian immunodefi- ciency virus in macaques. J. Virol. 66:5937-5948.
243. Paillart, J. C., M. Shehu-Xhilaga, R. Marquet, and J. Mak. 2004. Dimerization of retroviral RNA genomes: an inseparable pair. Nat. Rev. Microbiol. 2:461-472.
244. Panganiban, A. T., and D. Fiore. 1988. Ordered interstrand and intrastrand DNA transfer during reverse transcription. Science 241:1064-1069.
245. Parthasarathi, S., A. Varela-Echavarria, Y. Ron, B. D. Preston, and J. P. Dougherty. 1995. Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications. J. Virol. 69:7991-8000.
246. Patel, P., D. L. Hanson, P. S. Sullivan, R. M. Novak, A. C. Moorman, T. C. Tong, S. D. Holmberg, and J. T. Brooks. 2008. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann. Intern. Med. 148:728-736.
247. Patel, P. H., and B. D. Preston. 1994. Marked infidelity of human immunodeficiency virus type 1 reverse transcriptase at RNA and DNA template ends. Proc. Natl. Acad. Sci. USA 91:549-553.
248. Pathak, V. K., and H. M. Temin. 1990. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc. Natl. Acad. Sci. USA 87:6024-6028.
249. Peeters, M., F. Liegeois, N. Torimiro, A. Bourgeois, E. Mpoudi, L. Vergne, E. Saman, E. Delaporte, and S. Saragosti. 1999. Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient. J. Virol. 73:7368-7375. (Pubitemid 29383220)
250. Peliska, J. A., and S. J. Benkovic. 1994. Fidelity of in vitro DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase. Biochemistry 33:3890-3895. (Pubitemid 24125352)
251. Peliska, J. A., and S. J. Benkovic. 1992. Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase. Science 258:1112-1118.
252. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586.
253. Pernas, M., C. Casado, R. Fuentes, M. J. Perez-Elias, and C. Lopez- Galindez. 2006. A dual superinfection and recombination within HIV-1 subtype B 12 years after primoinfection. J. Acquir. Immune Defic. Syndr. 42:12-18.
254. Perrino, F. W., B. D. Preston, L. L. Sandell, and L. A. Loeb. 1989. Extension of mismatched 3′ termini of DNA is a major determinant of the infidelity of human immunodeficiency virus type 1 reverse transcriptase. Proc. Natl. Acad. Sci. USA 86:8343-8347.
255. Pfeiffer, J. K., M. M. Georgiadis, and A. Telesnitsky. 2000. Structure-based Moloney murine leukemia virus reverse transcriptase mutants with altered intracellular direct repeat deletion frequencies. J. Virol. 74:9629-9636.
256. Pfeiffer, J. K., and A. Telesnitsky. 2001. Effects of limiting homology at the site of intermolecular recombinogenic template switching during Moloney murine leukemia virus replication. J. Virol. 75:11263-11274.
257. Pfeiffer, J. K., R. Topping, N.-H. Shin, and A. Telesnitsky. 1999. Altering the intracellular environment increases the frequency of tandem repeat deletion during Moloney murine leukemia virus reverse transcription. J. Virol. 73:8441-8447.
258. Philpott, S., H. Burger, C. Tsoukas, B. Foley, K. Anastos, C. Kitchen, and B. Weiser. 2005. Human immunodeficiency virus type 1 genomic RNA sequences in the female genital tract and blood: compartmentalization and intrapatient recombination. J. Virol. 79:353-363. (Pubitemid 39648389)
259. Piantadosi, A., B. Chohan, V. Chohan, R. S. McClelland, and J. Overbaugh. 2007. Chronic HIV-1 infection frequently fails to protect against superinfection. PLoS Pathog. 3:e177. (Pubitemid 350291609)
260. Pierson, T. C., Y. Zhou, T. L. Kieffer, C. T. Ruff, C. Buck, and R. F. Siliciano. 2002. Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection. J. Virol. 76:8518-8531. (Pubitemid 34864046)
261. Pillai, S., J. Wong, and J. Barbour. 2008. Turning up the volume on mutational pressure: is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC.) Retrovirology 5:26.
262. Pion, M., G. Sanchez, V. Liska, L. Bettendroffer, D. Candotti, A. L. Chenine, F. Gondois-Rey, C. Tamalet, R. Vigne, R. M. Ruprecht, H. Agut, and I. Hirsch. 2003. Truncated forms of human and simian immunodeficiency virus in infected individuals and rhesus macaques are unique or rare quasispecies. Virology 311:157-168. (Pubitemid 36798110)
263. Preston, B. D., and J. P. Dougherty. 1996. Mechanisms of retroviral mutation. Trends Microbiol. 4:16-21.
264. Pulsinelli, G. A., and H. M. Temin. 1994. High rate of mismatch extension during reverse transcription in a single round of retrovirus replication. Proc. Natl. Acad. Sci. USA 91:9490-9494.
265. Quinones-Mateu, M. E., and E. J. Arts. 1999. Recombination in HIV-1: update and implications. AIDS Rev. 1:89-100.
266. Quinones-Mateu, M. E., Y. Gao, S. C. Ball, A. J. Marozsan, A. Abraha, and E. J. Arts. 2002. In vitro intersubtype recombinants of human immunode- ficiency virus type 1: comparison to recent and circulating in vivo recombinant forms. J. Virol. 76:9600-9613.
267. Rambaut, A., D. Posada, K. A. Crandall, and E. C. Holmes. 2004. The causes and consequences of HIV evolution. Nat. Rev. Genet. 5:52-61.
268. Ramirez, B. C., E. Simon-Loriere, R. Galetto, and M. Negroni. 2008. Implications of recombination for HIV diversity. Virus Res. 134:64-73.
269. Ramos, A., D. J. Hu, L. Nguyen, K. Phan, S. Vanichseni, N. Promadej, K. Choopanya, M. Callahan, N. L. Young, J. McNicholl, T. D. Mastro, T. M. Folks, and S. Subbarao. 2002. Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J. Virol. 76:7444-7452. (Pubitemid 34760966)
270. Rasmussen, S. V., and F. S. Pedersen. 2006. Co-localization of gammaretroviral RNAs at their transcription site favours co-packaging. J. Gen. Virol. 87:2279-2289.
271. Ray, N., J. E. Harrison, L. A. Blackburn, J. N. Martin, S. G. Deeks, and R. W. Doms. 2007. Clinical resistance to enfuvirtide does not affect susceptibility of human immunodeficiency virus type 1 to other classes of entry inhibitors. J. Virol. 81:3240-3250. (Pubitemid 46456633)
272. Rein, A. 1994. Retroviral RNA packaging: a review. Arch. Virol. Suppl. 9:513-522.
273. Rein, A., L. E. Henderson, and J. G. Levin. 1998. Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication. Trends Biochem. Sci. 23:297-301.
274. Rhode, B. W., M. Emerman, and H. M. Temin. 1987. Instability of large direct repeats in retrovirus vectors. J. Virol. 61:925-927.
275. Rhodes, T., H. Wargo, and W. S. Hu. 2003. High rates of human immunodeficiency virus type 1 recombination: near-random segregation of markers one kilobase apart in one round of viral replication. J. Virol. 77:11193-11200.
276. Rhodes, T. D., O. Nikolaitchik, J. Chen, D. Powell, and W. S. Hu. 2005. Genetic recombination of human immunodeficiency virus type 1 in one round of viral replication: effects of genetic distance, target cells, accessory genes, and lack of high negative interference in crossover events. J. Virol. 79:1666-1677.
277. Rittinger, K., G. Divita, and R. S. Goody. 1995. Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors. Proc. Natl. Acad. Sci. USA 92:8046-8049.
278. Robertson, D. L., F. Gao, B. H. Hahn, and P. M. Sharp. 1997. Intersubtype recombinant HIV-1 sequences. In B. Korber (ed.), Human retroviruses and AIDS 1997: a compilation and analysis of nucleic acid and amino acid sequences. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM.
279. Robinson, H. L., and D. M. Zinkus. 1990. Accumulation of human immunodeficiency virus type 1 DNA in T cells: results of multiple infection events. J. Virol. 64:4836-4841. (Pubitemid 20329803)
280. Roda, R. H., M. Balakrishnan, M. N. Hanson, B. M. Wohrl, S. F. Le Grice, B. P. Roques, R. J. Gorelick, and R. A. Bambara. 2003. Role of the reverse transcriptase, nucleocapsid protein, and template structure in the two-step transfer mechanism in retroviral recombination. J. Biol. Chem. 278:31536-31546.
281. Roda, R. H., M. Balakrishnan, J. K. Kim, B. P. Roques, P. J. Fay, and R. A. Bambara. 2002. Strand transfer occurs in retroviruses by a pause-initiated two-step mechanism. J. Biol. Chem. 277:46900-46911.
282. Roeth, J. F., and K. L. Collins. 2006. Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways. Microbiol. Mol. Biol. Rev. 70:548-563.
283. Rong, R., F. Bibollet-Ruche, J. Mulenga, S. Allen, J. L. Blackwell, and C. A. Derdeyn. 2007. Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection. J. Virol. 81:1350-1359. (Pubitemid 46167856)
284. Rulli, S. J., Jr., C. S. Hibbert, J. Mirro, T. Pederson, S. Biswal, and A. Rein. 2007. Selective and nonselective packaging of cellular RNAs in retrovirus particles. J. Virol. 81:6623-6631.
285. Sakalian, M., J. W. Wills, and V. M. Vogt. 1994. Efficiency and selectivity of RNA packaging by Rous sarcoma virus Gag deletion mutants. J. Virol. 68:5969-5981. (Pubitemid 24258614)
286. Sakuragi, J.-I., T. Shioda, and A. Panganiban. 2001. Duplication of the primary encapsidation and dimer linkage region of human immunodefi- ciency virus type 1 RNA results in the appearance of monomeric RNA in virions. J. Virol. 75:2557-2565.
287. Sanchez, G., X. Xu, J. C. Chermann, and I. Hirsch. 1997. Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals. J. Virol. 71:2233-2240. (Pubitemid 27078604)
288. Sarafianos, S. G., K. Das, S. H. Hughes, and E. Arnold. 2004. Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases. Curr. Opin. Struct. Biol. 14:716-730.
289. Sato, H., Y. Tomita, K. Ebisawa, A. Hachiya, K. Shibamura, T. Shiino, R. Yang, M. Tatsumi, K. Gushi, H. Umeyama, S. Oka, Y. Takebe, and Y. Nagai. 2001. Augmentation of human immunodeficiency virus type 1 subtype E (CRF01-AE) multiple-drug resistance by insertion of a foreign 11-amino-acid fragment into the reverse transcriptase. J. Virol. 75:5604-5613. (Pubitemid 32488154)
290. Schatz, O., R. V. Cromme, T. Naas, D. Lindemann, J. Mous, and S. F. J. LeGrice. 1990. Inactivation of the RNaseH domain of HIV-1 reverse transcriptase blocks viral infectivity, p. 293-303. In T. Papas (ed.), Oncogenesis and AIDS. Portfolio Publishing, Houston, TX.
291. Schmitz, A., A. H. Lund, A. C. Hansen, M. Duch, and F. S. Pedersen. 2002. Target-cell-derived tRNA-like primers for reverse transcription support retroviral infection at low efficiency. Virology 297:68-77. (Pubitemid 34734911)
292. Seillier-Moiseiwitsch, F., B. H. Margolin, and R. Swanstrom. 1994. Genetic variability of the human immunodeficiency virus: statistical and biological issues. Annu. Rev. Genet. 28:559-596.
293. Shen, L., and R. F. Siliciano. 2008. Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. J. Allergy Clin. Immunol. 122:22-28.
294. Shen, P., and H. V. Huang. 1986. Homologous recombination in Escherichia coli: dependence on substrate length and homology. Genetics 112:441-457.
295. Shin, N. H., D. Hartigan-O'Connor, J. K. Pfeiffer, and A. Telesnitsky. 2000. Replication of lengthened Moloney murine leukemia virus genomes is impaired at multiple stages. J. Virol. 74:2694-2702.
296. Shiramizu, B. T., B. G. Herndier, and M. S. McGrath. 1993. Lentiviral integration in HIV associated T-cell lymphomas. J. Cell. Biochem. 17E:267.
297. Shriner, D., Y. Liu, D. C. Nickle, and J. I. Mullins. 2006. Evolution of intrahost HIV-1 genetic diversity during chronic infection. Evolution 60:1165-1176. (Pubitemid 44804475)
298. Smith, D. M., D. D. Richman, and S. J. Little. 2005. HIV superinfection. J. Infect. Dis. 192:438-444.
299. Smith, D. M., M. C. Strain, S. D. Frost, S. K. Pillai, J. K. Wong, T. Wrin, Y. Liu, C. J. Petropolous, E. S. Daar, S. J. Little, and D. D. Richman. 2006. Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. Virology 355:1-5.
300. Smith, R. A., L. A. Loeb, and B. D. Preston. 2005. Lethal mutagenesis of HIV. Virus Res. 107:215-228.
301. Song, R., J. Kafaie, L. Yang, and M. Laughrea. 2007. HIV-1 viral RNA is selected in the form of monomers that dimerize in a three-step proteasedependent process; the DIS of stem-loop 1 initiates viral RNA dimerization. J. Mol. Biol. 371:1084-1098.
302. St. Louis, D. C., D. Gotte, E. Sanders-Buell, D. W. Ritchey, M. O. Salminen, J. K. Carr, and F. E. McCutchan. 1998. Infectious molecular clones with the nonhomologous dimer initiation sequences found in different subtypes of human immunodeficiency virus type 1 can recombine and initiate a spreading infection in vitro. J. Virol. 72:3991-3998.
303. Strappe, P. M., D. W. Hampton, D. Brown, B. Cachon-Gonzalez, M. Caldwell, J. W. Fawcett, and A. M. Lever. 2005. Identification of unique reciprocal and non reciprocal cross packaging relationships between HIV-1, HIV-2 and SIV reveals an efficient SIV/HIV-2 lentiviral vector system with highly favourable features for in vivo testing and clinical usage. Retrovirology 2:55.
304. Streeck, H., B. Li, A. F. Poon, A. Schneidewind, A. D. Gladden, K. A. Power, D. Daskalakis, S. Bazner, R. Zuniga, C. Brander, E. S. Rosenberg, S. D. Frost, M. Altfeld, and T. M. Allen. 2008. Immune-driven recombination and loss of control after HIV superinfection. J. Exp. Med. 205:1789-1796.
305. Stuhlmann, H., and P. Berg. 1992. Homologous recombination of copackaged retrovirus RNAs during reverse transcription. J. Virol. 66:2378-2388.
306. Subramanian, S., R. K. Mishra, and L. Singh. 2003. Genome-wide analysis of microsatellite repeats in humans: their abundance and density in specific genomic regions. Genome Biol. 4:R13.
307. Sugden, B. 1993. How some retroviruses got their oncogenes. Trends Biochem. Sci. 18:233-235.
308. Summers, J., and S. Litwin. 2006. Examining the theory of error catastrophe. J. Virol. 80:20-26.
309. Sun, G., P. K. O'Neil, H. Yu, Y. Ron, B. D. Preston, and J. P. Dougherty. 2001. Transduction of cellular sequence by a human immunodeficiency virus type 1-derived vector. J. Virol. 75:11902-11906. (Pubitemid 33063284)
310. Svarovskaia, E. S., K. A. Delviks, C. K. Hwang, and V. K. Pathak. 2000. Structural determinants of murine leukemia virus reverse transcriptase that affect the frequency of template switching. J. Virol. 74:7171-7178. (Pubitemid 30470703)
311. Swain, A., and J. M. Coffin. 1992. Mechanism of transduction by retroviruses. Science 255:841-845.
312. Swanson, C. M., and M. H. Malim. 2006. Retrovirus RNA trafficking: from chromatin to invasive genomes. Traffic 7:1440-1450. (Pubitemid 44524517)
313. Swanstrom, R., J. M. Bishop, and H. E. Varmus. 1982. Structure of a
314. Takebe, Y., and A. Telesnitsky. 2006. Evidence for the acquisition of multidrug resistance in an HIV-1 clinical isolate via human sequence transduction. Virology 351:1-6. (Pubitemid 44037669)
315. Takehisa, J., M. Osei-Kwasi, N. K. Ayisi, O. Hishida, T. Miura, T. Igarashi, J. Brandful, W. Ampofo, V. B. A. Netty, M. Mensah, M. Yamashita, E. Ido, and M. Hayami. 1997. Phylogenetic analysis of HIV type 2 in Ghana and intrasubtype recombination in HIV type 2. AIDS Res. Hum. Retrovir. 13:621-623.
316. Takehisa, J., L. Zekeng, E. Ido, Y. Yamaguchi-Kabata, I. Mboudjeka, Y. Harada, T. Miura, L. Kaptue, and M. Hayami. 1999. Human immunode- ficiency virus type 1 intergroup (M/O) recombination in Cameroon. J. Virol. 73:6810-6820. (Pubitemid 29327864)
317. Tapia, N., G. Fernandez, M. Parera, G. Gomez-Mariano, B. Clotet, M. Quinones-Mateu, E. Domingo, and M. A. Martinez. 2005. Combination of a mutagenic agent with a reverse transcriptase inhibitor results in systematic inhibition of HIV-1 infection. Virology 338:1-8. (Pubitemid 40835921)
318. Telesnitsky, A., and S. P. Goff. 1993. Strong-stop strand transfer during reverse transcription, p. 49-83. In A. M. Skalka and S. P. Goff (ed.), Reverse transcriptase. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
319. Telesnitsky, A., and S. P. Goff. 1993. Two defective forms of reverse transcriptase can complement to restore retroviral infectivity. EMBO J. 12:4433-4438. (Pubitemid 23302058)
320. Temin, H. M. 1993. Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation. Proc. Natl. Acad. Sci. USA 90:6900-6903.
321. Thomas, D. C., Y. A. Voronin, G. N. Nikolenko, J. Chen, W.-S. Hu, and V. K. Pathak. 2007. Determination of the ex vivo rates of human immunodeficiency virus type 1 reverse transcription by using novel strand-specific amplification analysis. J. Virol. 81:4798-4807.
322. Thomas, J. A., T. D. Gagliardi, W. G. Alvord, M. Lubomirski, W. J. Bosche, and R. J. Gorelick. 2006. Human immunodeficiency virus type 1 nucleocapsid zinc-finger mutations cause defects in reverse transcription and integration. Virology 353:41-51.
323. Thomson, M. M., and R. Najera. 2005. Molecular epidemiology of HIV-1 variants in the global AIDS pandemic: an update. AIDS Rev. 7:210-224.
324. Tillekeratne, L. M., A. Sherette, J. A. Fulmer, L. Hupe, D. Hupe, S. Gabbara, J. A. Peliska, and R. A. Hudson. 2002. Differential inhibition of polymerase and strand-transfer activities of HIV-1 reverse transcriptase. Bioorg. Med. Chem. Lett. 12:525-528.
325. Tisdale, M., T. Schulze, B. A. Larder, and K. Moelling. 1991. Mutations within the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase abolish virus infectivity. J. Gen. Virol. 72:59-66.
326. Tovanabutra, S., V. Watanaveeradej, K. Viputtikul, M. De Souza, M. H. Razak, V. Suriyanon, J. Jittiwutikarn, S. Sriplienchan, S. Nitayaphan, M. W. Benenson, N. Sirisopana, P. O. Renzullo, A. E. Brown, M. L. Robb, C. Beyrer, D. D. Celentano, J. G. McNeil, D. L. Birx, J. K. Carr, and F. E. McCutchan. 2003. A new circulating recombinant form, CRF15-01B, reinforces the linkage between IDU and heterosexual epidemics in Thailand. AIDS Res. Hum. Retrovir. 19:561-567.
327. Travers, K., S. Mboup, R. Marlink, A. Gueye-Nidaye, T. Siby, I. Thior, I. Traore, A. Dieng-Sarr, J. L. Sankale, C. Mullins, et al. 1995. Natural protection against HIV-1 infection provided by HIV-2. Science 268:1612-1615.
328. Tsuchihashi, Z., and P. O. Brown. 1994. DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 68:5863-5870. (Pubitemid 24258603)
329. van der Hoek, L., N. Back, M. F. Jebbink, A. de Ronde, M. Bakker, S. Jurriaans, P. Reiss, N. Parkin, and B. Berkhout. 2005. Increased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-acid insert in the reverse transcriptase. J. Virol. 79:3536-3543.
330. van der Kuyl, A. C., K. Kozaczynska, R. van den Burg, F. Zorgdrager, N. Back, S. Jurriaans, B. Berkhout, P. Reiss, and M. Cornelissen. 2005. Triple HIV-1 infection. N. Engl. J. Med. 352:2557-2559.
331. van Wamel, J. L. B., and B. Berkhout. 1998. The first strand transfer during HIV-1 reverse transcription can occur either intramolecularly or intermolecularly. Virology 244:245-251.
332. Varela-Echavarria, A., C. M. Prorock, Y. Ron, and J. P. Dougherty. 1993. High rate of genetic rearrangement during replication of a Moloney murine leukemia virus-based vector. J. Virol. 67:6357-6364. (Pubitemid 23309099)
333. Vilcek, S., I. Greiser-Wilke, P. Nettleton, and D. J. Paton. 2000. Cellular insertions in the NS2-3 genome region of cytopathic bovine viral diarrhoea virus (BVDV) isolates. Vet. Microbiol. 77:129-136.
334. Vogt, P. K. 1997. Historical introduction to the general properties of retroviruses, p. 1-25. In J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
335. Vogt, V. M. 1997. Retroviral virions and genomes, p. 27-69. In J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
336. Voisset, C., R. A. Weiss, and D. J. Griffiths. 2008. Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease. Microbiol. Mol. Biol. Rev. 72:157-196.
337. Voynow, S. L., and J. M. Coffin. 1985. Evolutionary variants of Rous sarcoma virus: large deletion mutants do not result from homologous recombination. J. Virol. 55:67-78.
338. Wain-Hobson, S., C. Renoux-Elbé, J.-P. Vartanian, and A. Meyerhans. 2003. Network analysis of human and simian immunodeficiency virus sequence sets reveals massive recombination resulting in shorter pathways. J. Gen. Virol. 84:885-895.
339. Waldman, A. S., and R. M. Liskay. 1987. Differential effects of base-pair mismatch on intrachromosomal versus extrachromosomal recombination in mouse cells. Proc. Natl. Acad. Sci. USA 84:5340-5344.
340. Wang, K., J. E. Mittler, and R. Samudrala. 2006. Comment on "Evidence for positive epistasis in HIV-1." Science 312:848.
341. Warrilow, D., L. Meredith, A. Davis, C. Burrell, P. Li, and D. Harrich. 2008. Cell factors stimulate human immunodeficiency virus type 1 reverse transcription in vitro. J. Virol. 82:1425-1437.
342. Wei, W., N. Gilbert, S. L. Ooi, J. F. Lawler, E. M. Ostertag, H. H. Kazazian, J. D. Boeke, and J. V. Moran. 2001. Human L1 retrotransposition: cis preference versus trans complementation. Mol. Cell. Biol. 21:1429-1439.
343. Weiss, R. 1982. Experimental biology and assay of RNA tumor viruses, p. 209-260. In R. Weiss, N. Teich, H. Varmus, and J. Coffin (ed.), RNA tumor viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
344. Wildum, S., M. Schindler, J. Munch, and F. Kirchhoff. 2006. Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection. J. Virol. 80:8047-8059. (Pubitemid 44182305)
345. Winters, M. A., and T. C. Merigan. 2005. Insertions in the human immunodeficiency virus type 1 protease and reverse transcriptase genes: clinical impact and molecular mechanisms. Antimicrob. Agents Chemother. 49:2575-2582.
346. Wooley, D. P., L. A. Bircher, and R. A. Smith. 1998. Retroviral recombination is nonrandom and sequence dependent. Virology 243:229-234.
347. Wooley, D. P., R. A. Smith, S. Czajak, and R. C. Desrosiers. 1997. Direct demonstration of retroviral recombination in a rhesus monkey. J. Virol. 71:9650-9653.
348. Wu, Y. 2008. The second chance story of HIV-1 DNA: unintegrated? Not a problem! Retrovirology 5:61.
349. Wyke, J. A., and J. A. Beamand. 1979. Genetic recombination in Rous sarcoma virus: the genesis of recombinants and lack of evidence for linkage between pol, env and src genes in three factor crosses. J. Gen. Virol. 43:349-364.
350. Xu, H., and J. D. Boeke. 1987. High-frequency deletion between homologous sequences during retrotransposition of Ty elements in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 84:8553-8557.
351. Yamaguchi, J., A. Vallari, N. Ndembi, R. Coffey, C. Ngansop, D. Mbanya, L. Kaptue, L. G. Gurtler, S. G. Devare, and C. A. Brennan. 2008. HIV type 2 intergroup recombinant identified in Cameroon. AIDS Res. Hum. Retrovir. 24:86-91.
352. You, J. C., and C. S. McHenry. 1993. HIV nucleocapsid protein. Expression in Escherichia coli, purification, and characterization. J. Biol. Chem. 268: 16519-16527.
353. You, J. C., and C. S. McHenry. 1994. Human immunodeficiency virus nucleocapsid protein accelerates strand transfer of the terminally redundant sequences involved in reverse transcription. J. Biol. Chem. 269:31491-31495.
354. Yu, H., A. E. Jetzt, and J. P. Dougherty. 1997. Use of single-cycle analysis to study rates and mechanisms of retroviral mutation. Methods 12:325-336. (Pubitemid 27371257)
355. Yu, H., A. E. Jetzt, Y. Ron, B. D. Preston, and J. P. Dougherty. 1998. The nature of human immunodeficiency virus type 1 strand transfers. J. Biol. Chem. 273:28384-28391.
356. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222. (Pubitemid 20149353)
357. Zeilfelder, U., O. Frank, S. Sparacio, U. Schon, V. Bosch, W. Seifarth, and C. Leib-Mosch. 2007. The potential of retroviral vectors to cotransfer human endogenous retroviruses (HERVs) from human packaging cell lines. Gene 390:175-179. (Pubitemid 46251607)
358. Zhang, J., and C. M. Sapp. 1999. Recombination between two identical sequences within the same retroviral RNA molecule. J. Virol. 73:5912-5917. (Pubitemid 29274878)
359. Zhang, J., L. Y. Tang, T. Li, Y. Ma, and C. M. Sapp. 2000. Most retroviral recombinations occur during minus-strand DNA synthesis. J. Virol. 74:2313-2322. (Pubitemid 30091486)
360. Zhang, J., and H. M. Temin. 1993. 3′ junctions of oncogene-virus sequences and the mechanisms for formation of highly oncogenic retroviruses. J. Virol. 67:1747-1751. (Pubitemid 23088343)
361. Zhang, J., and H. M. Temin. 1993. Rate and mechanism of nonhomologous recombination during a single cycle of retroviral replication. Science 259:234-238. (Pubitemid 23041801)
362. Zhang, J., and H. M. Temin. 1994. Retrovirus recombination depends on the length of sequence identity and is not error prone. J. Virol. 68:2409-2414. (Pubitemid 24091920)
363. Zhang, M., B. Gaschen, W. Blay, B. Foley, N. Haigwood, C. Kuiken, and B. Korber. 2004. Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 14:1229-1246. (Pubitemid 39585357)
364. Zhang, W.-H., C. K. Hwang, W. S. Hu, R. J. Gorelick, and V. K. Pathak. 2002. Zinc finger domain of murine leukemia virus nucleocapsid protein enhances the rate of viral DNA synthesis in vivo. J. Virol. 76:7473-7484.
365. Zheng, Y. H., H. Sentsui, T. Nakaya, Y. Kono, and K. Ikuta. 1997. In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: insertions/duplications at the principal neutralizing domain. J. Virol. 71:5031-5039.
366. Zhivotovsky, L. A., N. A. Rosenberg, and M. W. Feldman. 2003. Features of evolution and expansion of modern humans, inferred from genomewide microsatellite markers. Am. J. Hum. Genet. 72:1171-1186.
367. Zhuang, J., A. E. Jetzt, G. Sun, H. Yu, G. Klarmann, Y. Ron, B. D. Preston, and J. P. Dougherty. 2002. Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots. J. Virol. 76:11273-11282. (Pubitemid 35231282)
368. Zhuang, J., S. Mukherjee, Y. Ron, and J. P. Dougherty. 2006. High rate of genetic recombination in murine leukemia virus: implications for influencing proviral ploidy. J. Virol. 80:6706-6711. (Pubitemid 43927475)